Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice

Fitoterapia

Volumn 93, Issue , 2014, Pages 150-162

  Jeong, Kyong Ju ^a   Kim, Do Yeon ^a   Quan, Hai Yan ^a   Jo, Hee Kyung ^a   Kim, Go Woon ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMPK; CREB; Eugenol; Hepatic glucose production; Type 2 diabetes

Indexed keywords

CREB REGULATED TRANSCRIPTION COACTIVATOR 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EUGENOL; GLUCAGON; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN; PYRUVIC ACID; UNCLASSIFIED DRUG; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG SCREENING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; BLOOD; C57BL MOUSE; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; LIVER; METABOLISM; PHYTOTHERAPY; RANDOMIZATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EUGENOL; GLUCONEOGENESIS; GLUCOSE; GLUCOSE TOLERANCE TEST; HEPATOCYTES; INSULIN; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; PYRUVIC ACID; RANDOM ALLOCATION;

EID: 84893366176     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.12.023     Document Type: Article

References (32)

1. C. Bogardus, S. Lillioja, B.V. Howard, B. Reaven, and D. Mott Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects J Clin Invest 74 1984 1238 1246 (Pubitemid 15206819)
2. M. Stumvoll, N. Nurjhan, G. Perriello, G. Dailey, and J.E. Gerich Metabolic effects of metformin in non-insulin-dependent diabetes mellitus N Engl J Med 333 1995 550 554
3. M.Y. El-Mir, V. Nogueira, E. Fontaine, N. Avéret, M. Rigoulet, and X. Leverve Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I J Biol Chem 175 2000 223 228 (Pubitemid 30038975)
4. C.B. Yoo, K.T. Han, K.S. Cho, L. Ha, H.J. Park, and J.H. Nam et al. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells Cancer Lett 225 2005 41 52
5. K. Venkitanarayanan, A. Kollanoor-Johny, M.J. Darre, A.M. Donoghue, and D.J. Donoghue Use of plant-derived antimicrobials for improving the safety of poultry products Poult Sci 92 2013 493 501
6. B. Shah, P.M. Davidson, and Q. Zhong Nanodispersed eugenol has improved antimicrobial activity against Escherichia coli O157:H7 and Listeria monocytogenes in bovine milk Int J Food Microbiol 161 2013 53 59
7. Prasad S.N. Muralidhara Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence Neurol Res 38 2013 330 345
8. R. Grespan, M. Paludo, P. Lemos Hde, C.P. Barbosa, C.A. Bersani-Amado, and M.M. Dalalio et al. Anti-arthritic effect of eugenol on collagen-induced arthritis experimental model Biol Pharm Bull 35 2012 1818 1820
9. C.E. Ferland, F. Beaudry, and P. Vachon Antinociceptive effects of eugenol evaluated in a monoiodoacetate-induced osteoarthritis rat model Phytother Res 26 2012 1278 1285
10. S. Srinivasan, G. Sathish, M. Jayanthi, J. Muthukumaran, U. Muruganathan, and V. Ramachandran Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats Mol Cell Biochem 385 2014 159 168
11. K. Mnafgui, F. Kaanich, A. Derbali, K. Hamden, F. Derbali, and S. Slama et al. Inhibition of key enzymes related to diabetes and hypertension by eugenol in vitro and in alloxan-induced diabetic rats Arch Physiol Biochem 119 2013 225 233
12. P.O. Seqlen Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion Exp Cell Res 82 1973 391 398
13. Q.F. Collins, Y. Xiong Jr., E.G. Lupo, H.Y. Liu, and W. Cao p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes J Biol Chem 281 2006 24336 24344 (Pubitemid 44321471)
14. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab 9 2009 407 416
15. S.H. Koo, L. Flechner, L. Qi, X. Zhang, R.A. Screaton, and S. Jeffries et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism Nature 437 2005 1109 1111
16. D.G. Hardie The AMP-activated protein kinase pathway - new players upstream and downstream J Cell Sci 117 2004 5479 5487 (Pubitemid 40012195)
17. J.T. Rodgers, and P. Puigserver Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 Proc Natl Acad Sci U S A 104 2007 12861 12866 (Pubitemid 47255245)
18. K. Miyake, W. Ogawa, M. Matsumoto, T. Nakamura, H. Sakaue, and M. Kasuga Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver J Clin Invest 110 2002 1483 1491 (Pubitemid 35396919)
19. M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, and C. Dalla Man et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes Diabetes 53 2004 2048 2056
20. M. Roden, and E. Bernroider Hepatic glucose metabolism in humans - its role in health and disease Best Pract Res Clin Endocrinol Metab 17 2003 365 385
21. R.S. Hundal, M. Krssak, S. Dufour, D. Laurent, V. Lebon, and V. Chandramouli et al. Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2000 2063 2069
22. L.C. Glass, K. Cusi, R. Berria, R. Petz, E. Cersosimo, and R.A. Defronzo et al. Pioglitazone improvement of fasting and postprandial hyperglycemia in Mexican-American patients with type 2 diabetes: a double tracer OGTT study Clin Endocrinol 73 2010 339 345
23. S.J. Kim, H.D. Yuan, and S.H. Chung Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells Biol Pharm Bull 33 2010 325 328
24. H.Y. Quan, H.D. Yuan, M.S. Jung, S.K. Ko, Y.G. Park, and S.H. Chung Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice Int J Mol Med 29 2012 73 80
25. H.D. Yuan, D.Y. Kim, H.Y. Quan, S.J. Kim, M.S. Jung, and S.H. Chung Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3i via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells Chem Biol Interact 195 2012 35 42
26. A. Andrade-Cetto, and R.C. Vázquez Gluconeogenesis inhibition and phytochemical composition of two Cecropia species J Ethnopharmacol 130 2010 93 97
27. J.S. Gounarides, M. Korach-Andre, K. Killary, G. Argentieri, O. Turner, and D. Laurent Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model Endocrinology 149 2008 758 766 (Pubitemid 351159344)
28. B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, and L. Bertrand et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders J Physiol 574 2006 41 53 (Pubitemid 43905795)
29. B. Viollet, B. Guigas, J. Leclerc, S. Hébrard, L. Lantier, and R. Mounier et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives Acta Physiol 196 2009 81 98
30. K. Starowicz, S. Nigam, and V. DiMarzo Biochemistry and pharmacology of endovanilloids Pharmacol Ther 114 2007 13 33 (Pubitemid 46498161)
31. A. Szallasi, D.N. Cortright, C.A. Blum, and S.R. Eid The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of concept Nat Rev Drug Discov 6 2007 357 372 (Pubitemid 46705200)
32. M.S. Islam, and H. Choi Dietary red chilli (Capsicum frutescens L.) is insulinotropic rather than hypoglycemic in type 2 diabetes model of rats Phytother Res 22 2008 1025 1029